Navigation Links
Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
Date:7/10/2012

tailed clinical study protocol.

Dr. Gary P. Kobinger, Chief, Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, and a principal investigator of his study, said, "There have been limited new vaccine innovations with the potential to better protect the elderly against influenza. We are pleased to conduct this trial to evaluate this potential breakthrough influenza vaccine technology."

Dr. J. Joseph Kim, Inovio's President and CEO, said, "We recently reported protective levels of immune responses against six unmatched strains of influenza in our H5N1 clinical study and expect data in the third quarter from our second influenza study, which includes an H1N1 component and is being tested in a population less vulnerable to influenza. Having achieved best-in-class T-cell responses against other diseases, we will also assess T-cell generation against influenza, which is widely believed to be an important avenue to increasing protection for the highly at-risk 65-plus population."

With the vulnerability of elderly in mind, this clinical study will assess the ability to generally induce stronger antibody responses; provide universal cross-strain protection; and stimulate a part of the immune system not triggered by conventional influenza vaccines, the cellular immune response that generates CD8+ killer T-cells.

About SynCon® Influenza Vaccines and this Clinical Trial Design

The strategy to combine an influenza DNA vaccine prime with a conventional seasonal vaccine boost is based on the idea that combining the different modalities of Inovio's SynCon® flu vaccine's ability to generate cross-protective antibody and T-cell responses with the conventional seasonal flu vaccine in a prime-boost regimen could generate a stronger and broader antibody response in the elderly.

Inovio's SynCon® i
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Inovio Pharmaceuticals to Present at JMP Investor Conference
2. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
3. Inovio Pharmaceuticals to Present at SPI 2012
4. Inovio Pharmaceuticals Reports 2012 First Quarter Financial Results
5. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
6. Stryker Initiates Voluntary Product Recall of Modular-Neck Stems
7. MAQUET Initiates Class I Recall of the FLOW-i Anesthesia System
8. Oncos Therapeutics Initiates Phase I Clinical Study of CGTG-102, an Oncolytic Adenovirus for the Treatment of Solid Tumor Cancers
9. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
10. Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia
11. CSL Behring Initiates Study of Subcutaneous Administration of C1-esterase Inhibitor in Patients with Hereditary Angioedema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ... systems, announced today that the United States Food and ... Drug application(IND) for ORMD-0801, its oral insulin capsule. ... clearance to proceed," stated Nadav Kidron ... major milestone for Oramed and we look forward to ...
(Date:5/16/2013)... May 16, 2013  PTC Therapeutics, Inc., today announced ... S-1 with the U.S. Securities and Exchange Commission ("SEC") ... common stock. The number of shares to be offered ... been determined. (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ) ... as joint book-running managers for the offering. Cowen and ...
(Date:5/16/2013)... Calif. , May 16, 2013  Amgen (NASDAQ: ... Sciences Conference on Tuesday, May 21, 2013, at the Sheraton ... , beginning at 10:00 a.m. Eastern Daylight Time. ... president of Research and Development at Amgen, will present at ... from the Events Calendar on Amgen,s website, www.amgen.com , ...
Breaking Medicine Technology:Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
... May 2, 2011 Leading events organiser UBM ... of ICSE China, which is dedicated to pharmaceutical contract ... at the SNIEC China, is part of the most ... China for pharmaceutical ingredients, P-MEC China for pharma machinery ...
... 2, 2011 HealthWarehouse.com, Inc. (ticker: HEWA) a ... Lalit Dhadphale, President and CEO, will present at ... interactive, real-time virtual conference.DATE: , May 5, ... www.retailinvestorconferences.com >Click the red "register/ watch event now" ...
Cached Medicine Technology:ICSE China to Offer Inaugural Conference Programme in 2011 2ICSE China to Offer Inaugural Conference Programme in 2011 3HealthWarehouse.com, Inc. to Present Live at RetailInvestorConferences.com on May 5th 2
(Date:5/18/2013)... In a May 14, 2013 article entitled “Angelina Jolie ... Gene,” Fox News reported the movie star had opted ... a gene that doctors estimated gave her an 87 ... risk of ovarian cancer (go to: goo.gl/5JHBP). Ms. Jolie’s ... a blog post entitled “A Patient’s Journey: Angelina Jolie” ...
(Date:5/18/2013)... Coral Springs, FL (PRWEB) May 18, 2013 ... segment dedicated to the special places we call home. These ... found on maps. They are the locations where the people ... The first-rate show takes viewers off the highways and shares ... the best of both nations with an American sports and ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 Family Magazine of ... for excellence by Follow Media Consulting, Inc. in the category ... the continued commitment and dedication of the areas best in ... No one knows parenting better than Brenda Hyde, a mother ... to help parents know about the vast resources available to ...
(Date:5/18/2013)... 2013 The “Sleep Apnea Diagnostic & ... Masks, Adaptive Servo-Ventilation (ASV), Oral Appliances, Nasal EPAP, Neurostimulation] ... analyzes and studies the major market drivers, restraints, and ... the World. , Browse , ... Figures , 318 pagesand in-depth TOC ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 The California ... 2013 therapies. At the Ayurvedic Spa , the ... panchakarma practitioner and lifestyle recommendations and stress ... “knowledge of life", is the traditional healthcare system of ... life of harmony is the basis for all optimum ...
Breaking Medicine News(10 mins):Health News:Angelina Jolie – Scarless Breast Augmentation Surgery 2Health News:Communities of Distinction TV Presents "A Place to Call Home" Segment 2Health News:Summer Camps in DC "Best of the Best" Awarded to Family Magazine of Washington DC for Excellence by Follow Media Consulting, Inc. 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 3Health News:Ayurveda Spa Treatments Now Offered at the California College of Ayurveda Panchakarma Center 2
... WEDNESDAY, March 14 (HealthDay News) -- The number of ... imported food rose in recent years, according to a ... Centers for Disease Control and Prevention reviewed outbreaks reported ... 2005 and 2010. During those five years there were ...
... uniquely positioned to play a major role in reducing ... according to an analysis led by University of California, ... PhD , The team recommends a multipronged approach ... providing education, in addition to broader strategies to influence ...
... With spring planting season on the horizon, scientists are planting ... chicken and other fried items prepared in restaurants and other ... of heart-healthy soybean, canola and sunflower oils are the topic ... & Engineering News ( C&EN ), the weekly newsmagazine ...
... millions of molecules in a drop of a patient,s blood ... or a drug ferry that doesn,t release its toxic contents ... nanotechnologies could be game changers in how we diagnose, monitor ... Engineering at the California Institute of Technology, and a member ...
... eggs or ovarian tissue for the sole purpose of ... for society, according to a recent analysis by a ... -- freezing eggs or ovarian tissue -- was originally ... their fertility. But now, fertility centers around the ...
... estimate nearly 800,000 preventable adverse drug events may ... these incidents could be prevented with safety practices ... health care professionals, such as physicians, pharmacists and ... discrepancies when patients transfer between health care settings. ...
Cached Medicine News:Health News:Recent Rise Seen in Foodborne Diseases From Imports: CDC 2Health News:Ob-gyns can prevent negative health impacts of environmental chemicals 2Health News:Ob-gyns can prevent negative health impacts of environmental chemicals 3Health News:Planting the seeds for heart-healthier fries and other foods 2Health News:Fighting cancer with nanotechnology 2Health News:What does delaying childbearing cost? 2Health News:Increased collaboration between nursing home RNs and LPNs could improve patient care 2
... to direct a .038 inch ... to a specific renal area. ... inner stainless steel braid which ... catheter shaft. Supplied sterile in ...
Used to gain percutaneous access into the renal pelvis to treat stone disease. The dual lumen catheter and the Peel-Away® introducer are sized for use in pediatric patients. Supplied sterile in p...
Supplied sterile in peel-open packages. Intended for one-time use....
Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: